Krzysztof Sobczak Selected Research

Biomarkers (Surrogate Marker)

1/2019	Global Increase in Circular RNA Levels in Myotonic Dystrophy.
12/2018	Quantitative Methods to Monitor RNA Biomarkers in Myotonic Dystrophy.
12/2013	Splicing biomarkers of disease severity in myotonic dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Krzysztof Sobczak Research Topics

Disease

25	Myotonic Dystrophy (Dystrophia Myotonica) 08/2023 - 01/2007
5	Muscular Dystrophies (Muscular Dystrophy) 01/2022 - 12/2008
3	Fragile X Tremor Ataxia Syndrome 01/2021 - 01/2018
3	Neoplasms (Cancer) 01/2020 - 05/2002
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2018
2	Muscle Weakness 01/2019 - 03/2012
2	Myotonia 01/2016 - 04/2009
2	Inborn Genetic Diseases (Disease, Hereditary) 03/2012 - 05/2011
2	Huntington Disease (Huntington's Disease) 01/2012 - 05/2011
2	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2012 - 07/2009
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 02/2005 - 09/2004
1	Autistic Disorder (Autism) 08/2023
1	Abdominal Obesity 01/2023
1	Obesity 01/2023
1	Disease Progression 01/2022
1	Hypoxia (Hypoxemia) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2018
1	X-Linked Bulbo-Spinal Atrophy 05/2011
1	Carcinogenesis 01/2007
1	Ovarian Neoplasms (Ovarian Cancer) 05/2002
1	Breast Neoplasms (Breast Cancer) 05/2002

Drug/Important Bio-Agent (IBA)

18	RNA (Ribonucleic Acid)IBA 08/2023 - 12/2008
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2007
4	3' Untranslated Regions (3' UTR)IBA 01/2020 - 02/2012
3	RNA Splicing FactorsIBA 08/2023 - 10/2018
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2013
2	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2012
2	Nuclear Proteins (Protein, Nuclear)IBA 01/2021 - 01/2014
2	5' Untranslated Regions (5' UTR)IBA 01/2021 - 01/2018
2	polyglycineIBA 01/2021 - 01/2018
2	RNA Precursors (Precursor, mRNA)IBA 01/2020 - 01/2013
2	Nucleic AcidsIBA 01/2018 - 03/2015
2	Myotonin-Protein KinaseIBA 02/2013 - 02/2012
2	polyglutamineIBA 01/2012 - 05/2011
2	LigandsIBA 12/2009 - 07/2009
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Circular RNAIBA 01/2019
1	2,9-diamino-1,10-phenanthrolineIBA 12/2018
1	Protein Isoforms (Isoforms)IBA 10/2018
1	Fragile X Mental Retardation ProteinIBA 01/2018
1	Erythromycin (Erycette)FDA LinkGeneric 01/2016
1	Phosphotransferases (Kinase)IBA 01/2014
1	Calcium Channels (Calcium Channel)IBA 03/2012
1	Untranslated Regions (Untranslated Region)IBA 11/2011
1	Androgen Receptors (Androgen Receptor)IBA 05/2011
1	NucleotidesIBA 12/2009
1	Carrier Proteins (Binding Protein)IBA 07/2009
1	MorpholinosIBA 07/2009
1	Antisense OligonucleotidesIBA 07/2009
1	Chloride Channels (Chloride Channel)IBA 04/2009
1	EnzymesIBA 01/2007
1	DNA Polymerase beta (DNA Polymerase IV)IBA 01/2007
1	tributyl phosphate (TBP)IBA 02/2005
1	Ataxin-1IBA 09/2004
1	Ataxin-2IBA 09/2004
1	Messenger RNA (mRNA)IBA 05/2002
1	BRCA1 ProteinIBA 05/2002

Therapy/Procedure

1	Bariatric Surgery 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Aftercare (After-Treatment) 01/2018
1	Oral Administration 01/2016